Oligodendrocyte-specific protein peptides induce experimental autoimmune encephalomyelitis in SJL/J mice

Journal of Immunology

Volumn 162, Issue 12, 1999, Pages 7501-7509

  Stevens, David B ^a,b   Chen, Kendall ^a   Seitz, Robert S ^c   Sercarz, Eli E ^b   Bronstein, Jeff M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c Research Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CELL SPECIFICITY; DEMYELINATION; IMMUNE RESPONSE; MONONUCLEAR CELL; MOUSE; NONHUMAN; OLIGODENDROGLIA; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN STRUCTURE; REPORTER GENE; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES, T-LYMPHOCYTE; FEMALE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; PEPTIDE FRAGMENTS; SOLUBILITY; SPECIES SPECIFICITY; T-LYMPHOCYTES;

EID: 0033564328     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Storch, M., and H. Lassmann. 1997. Pathology and pathogenesis of demyelinating diseases. Curr. Opin. Neurol. 10:186.
2. Wucherpfennig, K. W., H. L. Weiner, and D. A. Hafler. 1991. T-cell recognition of myelin basic protein. Immunol. Today 12:277.
3. Tranquill, L. R., E. Skinner, C. Campagnoni, M. Vergelli, B. Hemmer, P. Muraro, R. Martin, H. F. McFarland, A. T. Campagnoni, and R. R. Voskuhl. 1996. Human T lymphocytes specific for the immunodominant 83-99 epitope of myelin basic protein: recognition of golli MBP HOG 7. J. Neurosci. Res. 45:820.
4. Sun, J. B., T. Olsson, W. Z. Wang, B. G. Xiao, V. Kostulas, S. Fredrikson, H. P. Ekre, and H. Link. 1991. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur. J. Immunol. 21:1461.
5. + T cells from multiple sclerosis patients. J. Neuroimmunol. 46:33.
6. Markovic-Plese, S., H. Fukaura, J. Zhang, A. al-Sabbagh, S. Southwood, A. Sette, V. K. Kuchroo, and D. A. Hafler. 1995. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J. Immunol. 155: 982.
7. Sun, J., H. Link, T. Olsson, B. G. Xiao, G. Andersson, H. P. Ekre, C. Linington, and P. Diener. 1991. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146:1490.
8. Kerlero de Rosbo, N., R. Milo, M. B. Lees, D. Burger, C. C. Bernard, and A. Ben-Nun. 1993. Reactivity to myelin antigens in multiple sclerosis: peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 92:2602.
9. Baig, S., T. Olsson, J. Yu-Ping, B. Hojeberg, M. Cruz, and H. Link. 1991. Multiple sclerosis: cells secreting antibodies against myelin-associated glycoprotein are present in cerebrospinal fluid. Scand. J. Immunol. 33:73.
10. Moller, J. R., D. Johnson, R. O. Brady, W. W. Tourtellotte, and R. H. Quarles. 1989. Antibodies to myelin-associated glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 22:55.
11. Johnson, D., D. A. Hafler, R. J. Fallis, M. B. Lees, R. O. Brady, R. H. Quarles, and H. L. Weiner. 1986. Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis. J. Neuroimmunol. 13:99.
12. Wajgt, A., and M. Gorny. 1983. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis: evidence of the intrathecal production of antibodies. Acta Neurol. Scand. 68:337.
13. Zhang, Y., D. Burger, G. Saruhan, M. Jeannet, and A. J. Steck. 1993. The T-lymphocyte response against myelin-associated glycoprotein and myelin basic protein in patients with multiple sclerosis. Neurology 43:403.
14. Banki, K., E. Colombo, F. Sia, D. Halladay, D. H. Mattson, A. H. Tatum, P. T. Massa, P. E. Phillips, and A. Perl. 1994. Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J. Exp. Med. 180:1649.
15. Schmidt, S., C. Linington, F. Zipp, S. Sotgiu, R. de Waal Malefyt, H. Wekerle, and R. Hohlfeld. 1997. Multiple sclerosis: comparison of the human T-cell response to S100 β and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis. Brain 120:1437.
16. van Noort, J. M., A. C. van Sechel, J. J. Bajramovic, M. el Ouagmiri, C. H. Polman, H. Lassmann, and R. Ravid. 1995. The small heat-shock protein α B-crystallin as candidate autoantigen in multiple sclerosis. Nature 375:798.
17. Rosener, M., P. A. Muraro, A. Riethmuller, M. Kalbus, G. Sappler, R. J. Thompson, R. Lichtenfels, N. Sommer, H. F. McFarland, and R. Martin. 1997. 2′,3′-cyclic nucleotide 3′-phosphodiesterase: a novel candidate autoantigen in demyelinating diseases. J. Neuroimmunol. 75:28.
18. Walsh, M. J., and J. M. Murray. 1998. Dual implication of 2′,3′-cyclic nucleotide 3′ phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis. J. Clin. Invest. 101:1923.
19. Rose, N. R., and C. Bona. 1993. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol. Today 14:426.
20. Lehmann, P. V., T. Forsthuber, A. Miller, and E. E. Sercarz. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155.
21. McRae, B. L., C. L. Vanderlugt, M. C. Dal Canto, and S. D. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75.
22. Yu, M., J. M. Johnson, and V. K. Tuohy. 1996. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183:1777.
23. Bronstein, J. M., P. Popper, P. E. Micevych, and D. B. Farber. 1996. Isolation and characterization of a novel oligodendrocyte-specific protein. Neurology 47:772.
24. Bronstein, J. M., P. E. Micevych, and K. Chen. 1997. Oligodendrocyte-specific protein (OSP) is a major component of CNS myelin. J. Neurosci. Res. 50:713.
25. Lupski, J. R., R. M. de Oca-Luna, S. Slaugenhaupt, L. Pentao, V. Guzzetta, B. J. Trask, O. Saucedo-Cardenas, D. F. Barker, J. M. Killian, C. A. Garcia, et al. 1991. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66:219.
26. Chance, P. F., M. K. Alderson, K. A. Leppig, M. W. Lensch, N. Matsunami, B. Smith, P. D. Swanson, S. J. Odelberg, C. M. Disteche, and T. D. Bird. 1993. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72:143.
27. Suter, U., A. A. Welcher, T. Ozcelik, G. J. Snipes, B. Kosaras, U. Francke, S. Billings-Gagliardi, R. L. Sidman, and E. M. Shooter. 1992. Trembler mouse carries a point mutation in a myelin gene. Nature 356:241.
28. Bronstein, J. M., R. L. Lallone, R. S. Seitz, G. W. Ellison, and L. W. Myers. 1999. A humoral response to oligodendrocyte-specific protein in multiple sclerosis: a molecular mimic. Neurology. In press.
29. Tuohy, V. K., Z. Lu, R. A. Sobel, R. A. Laursen, and M. B. Lees. 1989. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142:1523.
30. Swanborg, R. H. 1988. Experimental allergic encephalomyelitis. Methods Enzymol. 162:413.
31. Bronstein, J. M., C. G. Wasterlain, D. Bok, R. Lasher, and D. B. Farber. 1988. Localization of retinal calmodulin kinase. Exp. Eye Res. 47:391.
32. Amor, S., N. Groome, C. Linington, M. M. Morris, K. Dommair, M. V. Gardinier, J. M. Matthieu, and D. Baker. 1994. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153:4349.
33. Puckett, C., L. Hudson, K. Ono, V. Friedrich, J. Benecke, M. Dubois-Dalcq, and R. A. Lazzarini. 1987. Myelin-specific proteolipid protein is expressed in myelinating Schwann cells but is not incorporated into myelin sheaths. J. Neurosci. Res. 18:511.
34. Pham-Dinh, D., M. C. Birling, G. Roussel, A. Dautigny, and J. L. Nussbaum. 1991. Proteolipid DM-20 predominates over PLP in peripheral nervous system. Neuroreport 2:89.
35. Agrawal, H. C., and D. Agrawal. 1991. Proteolipid protein and DM-20 are synthesized by Schwann cells, present in myelin membrane, but they are not fatty acylated. Neurochem. Res. 16:855.
36. Linington, C., M. Webb, and P. L. Woodhams. 1984. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J. Neuroimmunol. 6:387.
37. Pham-Dinh, D., M. G. Mattei, J. L. Nussbaum, G. Roussel, P. Pontarotti, N. Roeckel, I. H. Mather, K. Artzt, K. F. Lindahl, and A. Dautigny. 1993. Myelin/ oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc. Natl. Acad. Sci. USA 90:7990.
38. Lebar, R., C. Lubetzki, C. Vincent, P. Lombrail, and J. M. Boutry. 1986. The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane. Clin. Exp. Immunol. 66:423.
39. Brunner, C., H. Lassmann, T. V. Waehneldt, J. M. Matthieu, and C. Linington. 1989. Differential ultrastructural localization of myelin basic protein, myelin/ oligodendroglial glycoprotein, and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats. J. Neurochem. 52:296.
40. Genain, C. P., M. H. Nguyen, N. L. Letvin, R. Pearl, R. L. Davis, M. Adelman, M. B. Lees, C. Linington, and S. L. Hauser. 1995. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest. 96:2966.
41. Lees, M. B. a. B., and O. A. 1992. Structure and acylation of proteolipid protein. In Myelin: Biology and Chemistry. R. E. Martenson, ed. CRC Press, Boca Raton, p. 237.
42. Sercarz, E. E., P. V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729.
43. k. Immunol. Rev. 151:81.
44. k-restricted determinant of hen egg lysozyme: limitations of lymph node proliferation studies in defining immunodominance and crypticity. Proc. Natl. Acad. Sci. USA 92:2214.
45. Kies, M. W. 1965. Chemical studies on an encephalitogenic protein from guinea pig brain. Ann. NY Acad. Sci. 122:161.
46. Nakao, A., and E. Roboz-Einstein. 1965. Chemical and immunochemical studies with dialyzable encephalitogenic compound from bovine spinal cord. Ann. NY Acad. Sci. 122:171.
47. Trotter, J. L., H. B. Clark, K. G. Collins, C. L. Wegeschiede, and J. D. Scarpellini. 1987. Myelin proteolipid protein induces demyelinating disease in mice. J. Neurol. Sci. 79:173.
48. Tuohy, V. K., R. A. Sobel, and M. B. Lees. 1988. Myelin proteolipid protein-induced experimental allergic encephalomyelitis: variations of disease expression in different strains of mice. J. Immunol. 140:1868.
49. Johns, T. G., N. Kerlero de Rosbo, K. K. Menon, S. Abo, M. F. Gonzales, and C. C. Bernard. 1995. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 154:5536.
50. b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Eur. J. Immunol. 25:1951.
51. 1s. J. Immunol. 152:3711.
52. Amor, S., D. Baker, N. Groome, and J. L. Turk. 1993. Identification of a major encephalitogenic epitope of proteolipid protein (residues 56-70) for the induction of experimental allergic encephalomyelitis in Biozzi AB/H and nonobese diabetic mice. J. Immunol. 150:5666.
53. Tuohy, V. K., R. B. Fritz, and A. Ben-Nun. 1994. Self-determinants in autoimmune demyelinating disease: changes in T-cell response specificity. Curr. Opin. Immunol. 6:887.
54. Kerlero de Rosbo, N., I. Mendel, and A. Ben-Nun. 1995. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur. J. Immunol. 25:985.
55. Itoyama, Y., N. H. Sternberger, H. D. Webster, R. H. Quarles, S. R. Cohen, and E. P. Richardson Jr. 1980. Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions. Ann. Neurol. 7:167.
56. Quarles, R. H., D. Johnson, R. O. Brady, and N. H. Sternberger. 1981. Preparation and characterization of antisera to the myelin-associated glycoprotein. Neurochem. Res. 6:1115.
57. Berger, T., S. Weerth, K. Kojima, C. Linington, H. Wekerle, and H. Lassmann. 1997. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab. Invest. 76:355.
58. Birnbaum, G., L. Kotilinek, P. Schlievert, H. B. Clark, J. Trotter, E. Horvath, E. Gao, M. Cox, and P. E. Braun. 1996. Heat shock proteins and experimental autoimmune encephalomyelitis (EAE). 1. Immunization with a peptide of the myelin protein 2′,3′ cyclic nucleotide 3′ phosphodiesterase that is cross-reactive with a heat shock protein alters the course of EAE. J. Neurosci. Res. 44:381.
59. Franco, A., S. Southwood, T. Arrhenius, V. K. Kuchroo, H. M. Grey, A. Sette, and G. Y. Ishioka. 1994. T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelilis. Eur. J. Immunol. 24:940.
60. Karin, N., D. J. Mitchell, S. Brocke, N. Ling, and L. Steinman. 1994. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon γ and tumor necrosis factor α production. J. Exp. Med. 180:2227.
61. Kaufman, D. L., M. Clare-Salzler, J. Tian, T. Forsthuber, G. S. Ting, P. Robinson, M. A. Atkinson, E. E. Sercarz, A. J. Tobin, and P. V. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69.
62. Tisch, R., X. D. Yang, S. M. Singer, R. S. Liblau, L. Fugger, and H. O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72.